This article reviews the current literature regarding the role of home measurement of blood pressure (BP) in the management of hypertension. Subjects with hypertension can use simple automated devices to measure their own BP at home. The results can be accurate and reliable, and because multiple readings allow a mean value to be calculated, a better estimate of the underlying BP level is obtained. Home measurement of BP gives results which are equivalent to the accepted 'gold standard' measure of ambulatory BP values, whilst using a simpler and much less expensive technique which is therefore more widely available. Both methods are better than conventional office measurements in
Introduction
The management of patients with hypertension consumes a great deal of time and effort and yet there is evidence that it is both underdiagnosed and undertreated. 1, 2 Paradoxically there is also evidence that some patients are over treated because of spurious or 'white coat' hypertension (WCH). 3 Blood pressure (BP) is usually monitored using clinic measurements by a doctor or nurse. Such measurements are however subject to a large variability, and a mean of several measurements is held to be a more precise estimate of the underlying level of BP. 1 Ambulatory measurement (ABP) is regarded as the gold standard of measurement but in reality is expensive and infrequently used. Ambulatory BP levels are more closely correlated with long-term outcomes in hypertension than clinic measurements.
devices to measure BP accurately are readily and cheaply available. Does the availability of home BP (HBP) measurements improve the management of hypertension?
Guidelines from both the WHO-International Society of Hypertension and from the American Society of Hypertension recommend the use of home monitoring in certain circumstances.
As physicians treating hypertensive subjects, we are most interested in the prognosis of hypertension, and in basing treatment on predictions of morbidity. This review therefore examines the evidence that HBP measurement allows more accurate prediction of long-term morbidity due to hypertension than conventional clinic measurement, in adult subjects in primary care.
Materials and methods
Searches for existing evidence were carried out using Cochrane, Best Evidence, Medline, Embase, Sociofile, Cinahl, PsychLit and Sigle databases, and via the bibliographies of other evidence. The search strategy included MeSH terms hypertension, bloodpressure-monitoring-ambulatory, blood-pressuremonitors, and also 'home blood pressure' and 'self monitoring' as textword searches. Systematic reviews of evidence were supplemented by more recent randomised controlled trials (RCTs) and prognostic and diagnostic papers where appropriate.
Papers were selected for inclusion if they presented evidence comparing HBP with either clinic BP or ABP measurement, in managing hypertension in adults; and if the methodological quality was judged sound. Criteria for critical appraisal of the evidence were derived from the Evidence-Based Medicine Working Group, 6,7 Sackett 8 and Greenhalgh. 9 Criteria were selected according to the type of paper (relating to diagnosis, treatment, or prognosis) under evaluation.
A number of different types of evidence have been considered. There are guidelines, issued by the World Health Organisation, 1 by the British Hypertension Society 10 and the American Society of Hypertension.
11 These guidelines show a variable content of evidence-based and opinion-based recommendations. There are three review articles, one of which is primarily about ABP. 4, 5, 12 Six articles concern the prognostic value of ABP but only one 13 of HBP measurements. Other primary research reports the relationship between HBP and either clinic BP, ABP, or both. In discussing the findings I have given more weight to the findings of systematic reviews and controlled trials.
Results

Are HBP measurements reliable and accurate?
Patients find it difficult to use conventional sphygmomanometers with a stethoscope. Modern semiautomated devices are much easier to use and few patients have difficulties with these. A number of different brands and models are available. The British Hypertension Society (BHS) has set standards for accuracy and reliability, although only some automated home BP machines comply with these [14] [15] [16] and a recent study was only able to recommend five of 25 devices tested. 17 These five devices all met the criteria for accuracy set both by the Association for Advancement of Medical Instrumentation (AAMI) and by the BHS; briefly, a consistent performance at a difference of Ͻ5 mm Hg from a mercury device. All five currently validated and recommended devices are manufactured by Omron (model numbers HEM-705CP, HEM-722C, HEM-735C, HEM-713C and HEM-737 Intellisense).
The reliability of devices which fit around the upper arm is better than wrist or finger devices. Home measurement allows a number of readings to be taken and the mean level used to plan management. Regression to the mean appears to be minimal beyond 12-16 readings [18] [19] [20] although different authors have used different regimes and timings of measurements. A reasonable compromise would be to take 14 -21 readings over 7 days (two or three readings a day) with some readings taken at home and some taken at work, and this would allow surgery-or clinic-owned machines to be loaned to patients for 1 week at a time.
Is the home BP the same as clinic BP?
The normal range of home BP is not the same as for clinic levels. Studies have consistently found home levels to be lower than clinic levels. In population surveys the difference is shown to be approximately 10/5 mm Hg. 5, 21 Accepted upper limit of normal levels of clinic BP of (say) 140/90 mm Hg therefore translate into an upper limit of normal home BP of 130/85 mm Hg. Aylett 19 recommends correcting the home BP by adding 10 mm Hg to the home systolic and 5 mm Hg to the home diastolic levels in order to directly compare with clinic readings. This correction should of course also be used to interpret the home readings in the light of guidelines based on clinic readings. BHS guidelines recommending a treatment threshold of 160/100 mm Hg therefore translate into a threshold home BP of 150/95 mm Hg: in treating hypertension, a target BP level of less than 150/90 mm Hg will translate into a target home BP level of less than 140/85 mm Hg.
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Does HBP give useful prognostic information?
Ohkubo et al 13 report a prospective study of the relation between initial BP levels (home and clinic) and subsequent all-cause mortality in a cohort of 1789 rural Japanese. Mean duration of follow up was 6.6 years. They found that HBP was more strongly predictive of later mortality than clinic BP. Analysing both systolic and diastolic levels of clinic BP, initial (first two readings) HBP and multiple (more than three readings, mean number 20) HBP measurements, only the mean multiple home systolic BP was significantly correlated with subsequent mortality.
Ohkubo's small study is the only one to investigate directly the link between home blood pressure levels and prediction of long term morbidity from hypertension. 13 However, there is other good evidence which links HBP with ABP levels, and also which links ABP with prediction of long term morbidity.
Is HBP equivalent to ABP?
Ambulatory BP is regarded as the 'gold standard' of BP measurement.
A number of studies in both hypertensive and unscreened subjects have shown that HBP and mean daytime ABP are very close in value, and the mean difference to be only −1.7/+1.2 mm Hg. 3, 5, 22 Mean 24-h ABP tends to be rather lower than both daytime ABP (difference −5/−4 mm Hg) and HBP (−2/−1 mm Hg).
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ABP and prognosis in hypertension
ABP level is more closely associated with subsequent morbidity and mortality from hypertensive disease than is clinic BP.
Large prospective trials of prognosis have not been done using ABP, presumably because of complexity and expense. Perloff 23 showed that a higher than expected ABP was associated with a greater risk of long-term cardiovascular complications, including death, in a prospective study, and her report after longer follow-up 24 confirmed the prognostic value of ABP measurement. Surrogate measures of morbidity, using a variety of measures of end-organ damage from hypertension, show a strong link with ABP. 4, 12, [25] [26] [27] Hypertensive end-organ damage has in turn been shown to be predictive of important clinical outcomes. 28 ABP also predicts the regression of end-organ damage during treatment better than does clinic BP.
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Is the use of HBP feasible in practice?
A number of studies have shown that the technique is practicable and that subjects are capable of producing accurate and valid results.
19,30,31
How common is white coat hypertension?
WCH is spurious hypertension, where the clinic reading is raised but subsequent readings (which may be ambulatory, home or nurse measurements) are within the normal range. Estimates vary but it may be as much as one third of all subjects initially judged hypertensive. 19, 30, 32 It is generally thought that WCH does not need treatment so that failing to recognise WCH will lead to over treatment of hypertension. However, it remains uncertain whether WCH is a completely harmless condition: there is some evidence that measures of target organ damage are lower in WCH than in sustained hypertension but not as low as in controls. 19, 33, 34 What are the indications for home measurements?
HBP may be the best way of screening for WCH 35 and particularly in newly diagnosed and poorlycontrolled subjects.
The American Society of Hypertension recommend the use of HBP for 'the majority of patients with hypertension', and with four potential benefits: distinguishing sustained from 'white coat' hypertension, assessment of the response to medication, improved compliance, and possible reduction in costs. 11 The World Health Organisation guidelines for the management of hypertension accept that there is limited evidence about the prognostic value of home measurements, but speculate that home
Journal of Human Hypertension monitoring may 'favourably affect patients' perceptions of their hypertension . . . and improve adherence to treatment'. There is however little evidence relating to compliance or cost. One study 36 has shown that compliance was observed to be higher among subjects who carry out HBP compared with subjects who never do so. A single cost-effectiveness analysis from a US Health Maintenance Organisation 37 indicated lower overall costs when using HBP.
Dutch GPs appear to target their management decisions at a diastolic level of 100 mm Hg despite guidelines which recommend lowering diastolic BP to 90 mm Hg. 2 This may indicate that doubt in the mind of the physician over the reliability and validity of one or two casual measurements of BP can undermine adherence to guidelines. More readings of BP will increase the physician's confidence, and home measurement is a convenient way to obtain more readings.
Therefore the main indications for HBP are to exclude WCH in new and poorly-controlled subjects and to encourage compliance in those with a history of poor compliance with drug therapy.
Are there contra-indications for home measurements?
Very little has been written. Nordmann found that subjects' reports of their home BP were more likely to be inaccurate when the subjects were of a low educational level. 31 Irregularity of the pulse may render the results less accurate 5, 38 so atrial fibrillation may be a contra-indication.
The need for future research
No evidence was found as to whether using HBP leads to changes in medication, or is in a general sense cost-effective (other than the study referred to above). It is also not known whether subjects prefer home or clinic measurements, and whether those using HBP have better control of their BP.
Further research is required to clarify these questions, as well as to confirm whether HBP gives better prognostic information than clinic BP.
